Targeted AML therapy: new biologic paradigms and therapeutic opportunities

被引：11
|
作者：
Willman, CL
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Canc Res Facil, Albuquerque, NM USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM USA
来源：
LEUKEMIA | 2001年 / 15卷 / 04期
关键词：
D O I：
10.1038/sj.leu.2402087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：690 / 694
页数：5
相关论文
共 50 条
  • [31] SJP1604, a novel targeted therapeutic agent for AML (acute myeloid leukemia) including standard therapy-resistant AML
    Um, Jihyun
    Lee, Dohyeong
    Oh, Jisun
    Park, Yongbin
    Moon, Sung Hwan
    Lee, Su Jin
    Ki, Min-Hyo
    Cho, Eui Hwan
    CANCER RESEARCH, 2019, 79 (13)
  • [32] NEW BIOLOGIC OPPORTUNITIES FOR CLINICAL GENETIC INVESTIGATION
    GERSHON, ES
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 620 - 621
  • [33] New paradigms for therapy for osteosarcoma
    Nagarajan R.
    Clohisy D.
    Weigel B.
    Current Oncology Reports, 2005, 7 (6) : 410 - 414
  • [34] Revealing targeted therapeutic opportunities in triple-negative breast cancers A new strategy
    Poage, Graham M.
    Hartman, Zachary C.
    Brown, Powel H.
    CELL CYCLE, 2013, 12 (17) : 2705 - 2706
  • [35] Therapeutic Potential of Targeted HOXA-TALE Knockdown in AML
    Dickson, Glenda Joanne
    O'Hagan, Kathleen A.
    Finnegan, Damian P. J.
    McMullin, Mary Frances
    Mills, Ken I.
    Lappin, Terence R. J.
    Thompson, Alexander
    BLOOD, 2011, 118 (21) : 1479 - 1479
  • [36] A NEW PARADIGM FOR CANCER THERAPY: A TARGETED SYSTEMIC PREVENTIVE/THERAPEUTIC APPROACH
    Crawford, S.
    ANNALS OF ONCOLOGY, 2013, 24 : 18 - 18
  • [37] Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach
    Mahhengam, Negah
    Kazemnezhad, Kimia
    Budi, Hendrik Setia
    Ansari, Mohammad Javed
    Bokov, Dmitry Olegovich
    Suksatan, Wanich
    Thangavelu, Lakshmi
    Siahmansouri, Homayoon
    JOURNAL OF DRUG TARGETING, 2022, 30 (05) : 494 - 510
  • [38] Targeted Therapy of FLT3 mutated AML
    Fiedler, W.
    Heuser, M.
    Kayser, S.
    Kebenko, M.
    Krauter, J.
    Salih, H. R.
    Goetze, K.
    Stamm, H.
    Latuske, E.
    Wellbrock, J.
    Doehner, K.
    Ganser, A.
    Doehner, H.
    Schlenk, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 21 - 21
  • [39] The true impact of new targeted therapies for AML
    Rowe, Jacob M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) : 1 - 4
  • [40] New Opportunities and Novel Paradigms to Support Neuromuscular Research
    Lieber, Richard
    Ward, Samuel
    Frank, Lawrence
    Schenk, Simon
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2012, 23 (01) : 95 - +
12345